564 related articles for article (PubMed ID: 35967323)
1. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
Front Immunol; 2022; 13():960733. PubMed ID: 35967323
[TBL] [Abstract][Full Text] [Related]
2. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.
Hsieh MH; Beirag N; Murugaiah V; Chou YC; Kuo WS; Kao HF; Madan T; Kishore U; Wang JY
Front Immunol; 2021; 12():641360. PubMed ID: 34054808
[TBL] [Abstract][Full Text] [Related]
3. A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.
Madan T; Biswas B; Varghese PM; Subedi R; Pandit H; Idicula-Thomas S; Kundu I; Rooge S; Agarwal R; Tripathi DM; Kaur S; Gupta E; Gupta SK; Kishore U
Am J Respir Cell Mol Biol; 2021 Jul; 65(1):41-53. PubMed ID: 33784482
[TBL] [Abstract][Full Text] [Related]
4. Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D.
Al-Ahdal MN; Murugaiah V; Varghese PM; Abozaid SM; Saba I; Al-Qahtani AA; Pathan AA; Kouser L; Nal B; Kishore U
Front Immunol; 2018; 9():1586. PubMed ID: 30105014
[TBL] [Abstract][Full Text] [Related]
5. Complement Activation-Independent Attenuation of SARS-CoV-2 Infection by C1q and C4b-Binding Protein.
Beirag N; Varghese PM; Neto MM; Al Aiyan A; Khan HA; Qablan M; Shamji MH; Sim RB; Temperton N; Kishore U
Viruses; 2023 May; 15(6):. PubMed ID: 37376569
[TBL] [Abstract][Full Text] [Related]
6. The S1 spike protein of SARS-CoV-2 upregulates the ERK/MAPK signaling pathway in DC-SIGN-expressing THP-1 cells.
Johnson EL; Ohkawa Y; Kanto N; Fujinawa R; Kuribara T; Miyoshi E; Taniguchi N
Cell Stress Chaperones; 2024 Apr; 29(2):227-234. PubMed ID: 38453000
[TBL] [Abstract][Full Text] [Related]
7. Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2.
Cramer J; Lakkaichi A; Aliu B; Jakob RP; Klein S; Cattaneo I; Jiang X; Rabbani S; Schwardt O; Zimmer G; Ciancaglini M; Abreu Mota T; Maier T; Ernst B
J Am Chem Soc; 2021 Oct; 143(42):17465-17478. PubMed ID: 34652144
[TBL] [Abstract][Full Text] [Related]
8. Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.
Al-Qahtani AA; Murugaiah V; Bashir HA; Pathan AA; Abozaid SM; Makarov E; Nal-Rogier B; Kishore U; Al-Ahdal MN
Immunobiology; 2019 May; 224(3):408-418. PubMed ID: 30954271
[TBL] [Abstract][Full Text] [Related]
9. DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.
Thépaut M; Luczkowiak J; Vivès C; Labiod N; Bally I; Lasala F; Grimoire Y; Fenel D; Sattin S; Thielens N; Schoehn G; Bernardi A; Delgado R; Fieschi F
PLoS Pathog; 2021 May; 17(5):e1009576. PubMed ID: 34015061
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
Roehrich H; Yuan C; Hou JH
Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
[TBL] [Abstract][Full Text] [Related]
11. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
[TBL] [Abstract][Full Text] [Related]
12. Protein-Protein Interaction between Surfactant Protein D and DC-SIGN
Dodagatta-Marri E; Mitchell DA; Pandit H; Sonawani A; Murugaiah V; Idicula-Thomas S; Nal B; Al-Mozaini MM; Kaur A; Madan T; Kishore U
Front Immunol; 2017; 8():834. PubMed ID: 28824609
[TBL] [Abstract][Full Text] [Related]
13. Surfactant protein D inhibits mite-induced alveolar macrophage and dendritic cell activations through TLR signalling and DC-SIGN expression.
Liu CF; Rivere M; Huang HJ; Puzo G; Wang JY
Clin Exp Allergy; 2010 Jan; 40(1):111-22. PubMed ID: 20205699
[TBL] [Abstract][Full Text] [Related]
14. Engineered Nanovesicles Expressing Bispecific Single Chain Variable Fragments to Protect against SARS-CoV-2 Infection.
Tang L; Ding H; Zeng Q; Zhou R; Liu B; Huang X
ACS Biomater Sci Eng; 2023 Dec; 9(12):6783-6796. PubMed ID: 37969099
[TBL] [Abstract][Full Text] [Related]
15. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
Paidi RK; Jana M; Mishra RK; Dutta D; Pahan K
J Immunol; 2021 Nov; 207(10):2521-2533. PubMed ID: 34645689
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues.
Cai G; Du M; Bossé Y; Albrecht H; Qin F; Luo X; Androulakis XM; Cheng C; Nagarkatti M; Nagarkatti P; Christiani DC; Whitfield ML; Amos CI; Xiao F
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502134
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.
Lu Q; Liu J; Zhao S; Gomez Castro MF; Laurent-Rolle M; Dong J; Ran X; Damani-Yokota P; Tang H; Karakousi T; Son J; Kaczmarek ME; Zhang Z; Yeung ST; McCune BT; Chen RE; Tang F; Ren X; Chen X; Hsu JCC; Teplova M; Huang B; Deng H; Long Z; Mudianto T; Jin S; Lin P; Du J; Zang R; Su TT; Herrera A; Zhou M; Yan R; Cui J; Zhu J; Zhou Q; Wang T; Ma J; Koralov SB; Zhang Z; Aifantis I; Segal LN; Diamond MS; Khanna KM; Stapleford KA; Cresswell P; Liu Y; Ding S; Xie Q; Wang J
Immunity; 2021 Jun; 54(6):1304-1319.e9. PubMed ID: 34048708
[TBL] [Abstract][Full Text] [Related]
18. Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors.
Pollastri S; Delaunay C; Thépaut M; Fieschi F; Bernardi A
Chem Commun (Camb); 2022 Apr; 58(33):5136-5139. PubMed ID: 35380569
[TBL] [Abstract][Full Text] [Related]
19. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.
Satta S; Meng Z; Hernandez R; Cavallero S; Zhou T; Hsiai TK; Zhou C
Theranostics; 2022; 12(6):2639-2657. PubMed ID: 35401811
[No Abstract] [Full Text] [Related]
20. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
Lempp FA; Soriaga LB; Montiel-Ruiz M; Benigni F; Noack J; Park YJ; Bianchi S; Walls AC; Bowen JE; Zhou J; Kaiser H; Joshi A; Agostini M; Meury M; Dellota E; Jaconi S; Cameroni E; Martinez-Picado J; Vergara-Alert J; Izquierdo-Useros N; Virgin HW; Lanzavecchia A; Veesler D; Purcell LA; Telenti A; Corti D
Nature; 2021 Oct; 598(7880):342-347. PubMed ID: 34464958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
